Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists

Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists

US Patent 7576077 · Granted Aug 18, 2009

Estimated economic value: $10,111,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Processes for preparing nitrosylated propanediols, compositions comprising the s2025
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2025
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2025
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2024
(R)-2-[(2H-1,3-benzodioxol-5-yl)methyl]pyrrolidine and processes for preparation2024
Petrolatum substitution preparation2024
Bronchodilating hetero-linked amides2023
Bronchodilating hetero-linked amides2023
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein int2022